Vaneck Biotech ETF (BBH)

$164.40 0.22 (0.13%)

15:28 EDT BBH Stock Quote Delayed 30 Minutes

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 3,447

Day's Range $163.88 - $165.28

52-Week Range $142.51 - $171.04

Dividend & Yield $0.75 (0.46%)

BBH Stock Predictions, Articles, and Vaneck Biotech ETF News

From the Web

How Are Biotech ETFs Reacting To These Q3 Earnings Releases?

From Talk Markets Nov 6, 2021

There's no denying that the pandemic has opened up investment opportunities in the biotech sector by triggering a race to introduce vaccines. Let’s take a look at big biotech earnings releases to see if these will impact ETFs exposed to the space.

Take A Look At The Top-Performing Biotech ETFs YTD

From Talk Markets Oct 2, 2021

The biotechnology sector has been grabbing the headlines on the new coronavirus vaccine and drug-related updates. The space has also kept its promise of generating returns, with the Nasdaq Biotechnology Index rising about 6.9% so far in 2021.

Biotech ETFs To Benefit From Latest Booster Update

From Talk Markets Aug 21, 2021

Vaccine makers like Moderna and Pfizer have reasons to cheer the update with regard to the application of boosters. The U.S. government announced plans to make COVID-19 vaccine boosters available from Sept. 20 onward. Here's ETFs that may benefit.

ETF Investing Areas to Consider for August

From Talk Markets Aug 9, 2021

There is no doubt that the second-quarter 2021 earnings season is going strong.

3 Biotech Stocks Wall Street Predicts Will Rally by More Than 170%

From StockNews.com Jul 22, 2021

The rapid spread of the COVID-19 Delta variant is fostering renewed investor interest in the biotech industry. Also, with the increasing demand for treatments for other critical diseases, the industry is expected to continue on a growth trajectory. So, we think it could be wise to bet on biotech stocks ASLAN Pharmaceuticals (ASLN), Aquestive Therapeutics (AQST), and Aravive (ARAV). They have promising portfolios of products and Wall Street analysts see tremendous upside potential for these stocks in the near term. Read on.

Moderna ETFs To Rise On Positive COVID-19 Vaccine Updates

From Talk Markets Jul 4, 2021

The competition to come up with a vaccine is opening up near-term opportunities, making the biotech sector a prospective space for investments. Therefore, we discuss a few ETFs that provide exposure to Moderna.

ADVERTISEMENT